Senozan, N. M. et al., Hemocyanin of the giant keyhole limpet, Megathura crenulata, in: "Invertebrate Oxygen-Binding Proteins", J. Lamy et al., eds., Marcel Dekker, Inc., N.Y., pp. 703-717 (1981). |
Herscowitz, H. B. et al., Immunochemical and immunogenic properties of a purified keyhole limpet haemocyanin, immunology 22:51-61 (1972). |
Curtis, J. E. et al., The human secondary immune response to keyhole limpet haemocyanin, Clin. Exp. Immunol. 10:171-177 (1972). |
Curtis, J. E. et al., The human primary immune response to keyhole limpet haemocyanin: Interrelatiolnships of delayed hypersensitivity, antibody response and in vitro blast transformation, Clin. Exp. Immunol. 6:473-491 (1970). |
Herskovits, T. T. et al., Subunit structure and hiugher order assembly of the hemocyanins of the melongenidae family: Melongena corona (Gmelin), Busycon canaliculatum (Linne), B. carica (Gmein), B. contrarium (Conrad), and B. spiratum (Lamarck). Comp. Biochem. Physiol. [B] 94B:415-421 (1989). |
Garvey, J. S., et al., High-molecular-weight hemocyanin. In: "Methods in Immunology", Addison-Wesley Publ. Co., pp. 135-139 (1977). |
Herskovits, T. T., Recent aspects of the subunit organization and dissociation of hemocyanins. Comp. Biochem. Physiol. 91B:597-611 (1988). |
Herskovits, T. T. et al., Higher order assemblies of molluscan hemocyanins. Comp. Bio chem. Physiol. [B] 99B:19-34 (1991). |
Savel-Niemann, A. et al., Keyhole limpet hemocyanin: On the structure of a widely used immunologic tool. In: "Invertebrate Dioxygen Carriers", G. Preaux et al., eds., Leuven University Press, Leuven, pp. 351-356 (1990). |
Markl, J. et al., The role of two distinct subunit types in the architecture of keyhole limpet hemocyanin (KLH). Naturwiss. 78:512-514 (1991). |
Van Holde, K. E. et al., The Hemocyanins. In: "Subunits in Biological Systems", S. N. Timasheff et al., eds. Marcel Dekker, N.Y., pp. 1-53 (1971). |
Ellerton, H. D. et al., Hemocyanin-A current perspective. Prog. Biophys. Mol. Biol. 41:143-248 (1983). |
Silverman, D. T. et al., Epidemiology of Bladder Cancer. In: "Hematology/Oncology Clinics of North America", P. W. Kantoff et al., eds., W. B. Saunders Co., Phila. p. 1 (1992). |
Itouku, K. A. et al., Superficial Bladder Cancer. In: "Hematology/Oncology Clinics of North America", P. W. Kantoff et al., eds., W. B. Saunders Co., Phila. pp. 99-116 (1992). |
Morales, A. et al., Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol. 116:180-183 (1976). |
Morales, A. et al., Immunotherapy for superficial bladder cancer. A developmental and clinical overview. Urol. Clin. Nor. Am. 19:549-556 (1992). |
Lamm, D. L., Optimal BCG treatment of superficial bladder cancer as defined by American trials. Eur. Urol. 21 Suppl. 2:12-16 (1992). |
Olsson, C. A. et al., Immunologic reduction of bladder cancer recurrence rate. J. Urol. 111:173-176 (1974). |
Jurincic, C. D. et al., Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study. J. Urol. 139:723-726 (1988). |
Flamm, J. et al., Recurrent superficial transitional cell carcinoma of the bladder: Adjuvant topical chemotherapy vs. immunotherapy. A prospective randomized trial. J. Uriol. 144:260-263 (1990). |
Kalble, T. et al. Intravesikale rezidivprophylaze beim oberflachlichen harnblasenkarzinom mit BCG und KLH. Urologe 30:118-121 (1991). |
Flamm, J. et al., Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder, Br. J. Urol. 67:70-73 (1991). |
Lamm, D. L. et al., Immunotherapy of murine transitional cell carcinoma. J. Urol. 128:1104-1108 (1982). |
Lamm, D. L. et al., Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma. Urol. Res. 9:227-230 (1981). |
Lamm, D. L. et al., Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH). J. Urol. 149:648-652 (1993). |
Laemmli, U. K., Clevage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685 (1970). |
Van Holde, K. E. et al., Boundary analysis of sedimentation-velocity experiments with monodisperse and paucidisperse solutes. Biopolym. 17:1387-1403 (1978). |
Vandenbark, A. A. et al., All KLH preparations are not created equal. Cell. Immunol. 60:240-243 (1981). |
Chodak, G. W. and Summerhayes, I., Detection of angiogenesis activity in malignant bladder tissue and cells. J. Urol. 132:1032 (1984). |
Shapiro, A., Ratliff, T. L., Oakley, D. M. and Catalona, W. J., Reduction of bladder tumor growth in mice treated with intravesical bacillus Calmette-Guerin and its correlation with bacillus Calmette-Guerin viability and natural killer cell activity. Cancer Res. 43:1611 (1983). |